Differentiated dendritic cells expressing nuclear RelB are predominantly located in rheumatoid synovial tissue perivascular mononuclear cell aggregates

Arthritis and Rheumatism

Volumn 43, Issue 4, 2000, Pages 791-800

  Pettit, Allison R ^a   MacDonald, Kelli P A ^a   O'Sullivan, Brendan ^a   Thomas, Ranjeny ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

HLA DR ANTIGEN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN;

ANTIGEN PRESENTING CELL; ARTICLE; CELL AGGREGATION; CELL DIFFERENTIATION; CELLULAR DISTRIBUTION; CLINICAL ARTICLE; CONTROLLED STUDY; DENDRITIC CELL; ELECTROPHORETIC MOBILITY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; RHEUMATOID ARTHRITIS; SYNOVIAL FLUID; SYNOVIUM; WESTERN BLOTTING;

ANTIGEN-PRESENTING CELLS; ARTHRITIS, RHEUMATOID; CELL DIFFERENTIATION; CELL NUCLEUS; DENDRITIC CELLS; DNA; DNA-BINDING PROTEINS; FLOW CYTOMETRY; HUMANS; IMMUNOHISTOCHEMISTRY; PROTO-ONCOGENE PROTEINS; RADIOALLERGOSORBENT TEST; SYNOVIAL FLUID; SYNOVIAL MEMBRANE; TRANSCRIPTION FACTOR RELB; TRANSCRIPTION FACTORS; TRANSLOCATION, GENETIC;

EID: 0033866750     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/1529-0131(200004)43:4<791::AID-ANR9>3.0.CO;2-E     Document Type: Article

References (48)

1. Functional differentiation of dendritic cells in rheumatoid arthritis: Role of CD86 in the synovium
2. Expression and function of CD80 and CD86 costimulator molecules on synovial dendritic cells in chronic arthritis
3. Circulating human dendritic cells differentially express high levels of a 55-kd actin-bundling protein
4. The actin-bundling protein fasein is involved in the formation of dendritic processes in maturing epidermal Langerhans cells
5. Dendritic cells in synovial fluid of chronic inflammatory arthritis lack CD80 surface expression
6. Antigen presenting cells in rheumatoid arthritis
7. Analysis of the synovial cell infiltrate in early rheumatoid synovial tissue in relation to local disease activity
8. Functional deficiency of antigen-presenting cells in the synovial fluid of rheumatoid arthritis
9. Dendritic cells in allergic and chronic inflammatory responses
10. Rheumatoid synovium is enriched in mature antigen-presenting dendritic cells
11. Human blood dendritic cells selectively express CD83, a member of the immunoglobulin superfamily
12. Expression of relB is required for the development of thymic medulla and dendritic cells
13. Multiorgan inflammation and hematopoietic abnormalities in mice with a targeted disruption of RelB, a member of the NF-kappa B/Rel family
14. Nuclear localization of RelB is associated with effective antigen-presenting cell function
15. Differential nuclear localization of p50, p52, and RelB proteins in human accessory cells of the immune response in situ
16. The NF-kB and IkB proteins: New discoveries and insights
17. Multi-step activation of NF-kappa B/Rel transcription factors
18. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis
19. Effects of pulse methylprednisolone on cell adhesion molecules in the synovial membrane in rheumatoid arthritis: Reduced E-selectin and intercellular adhesion molecule 1 expression
20. Isolation and characterization of human peripheral blood dendritic cells
21. The B7/BB1 antigen provides one of several costimulatory signals for the activation of CD4+ T lymphocytes by human blood dendritic cells in vitro
22. Monoclonal antibody EBM11 (anti-CD68) discriminates between dendritic cells and macrophages after short-term culture
23. - peripheral blood cells with dendritic precursor characteristics
24. Receptor-specific induction of NF-kappaB components in primary B cells
25. NF-kappa B and Rel: Participants in a multiform transcriptional regulatory system
26. Fascin, an actin-bundling protein, induces membrane protrusions and increases cell motility of epithelial cells
27. Differentiation of monocytes into dendritic cells in a model of transendothelial trafficking
28. RelB regulation of chemokine expression modulates local inflammation
29. The identification of germinal centres and follicular dendritic cell networks in rheumatoid synovial tissue
30. Follicular dendritic cells and germinal centers
31. CD40, but not lipopolysaccharide and anti-IgM stimulation of primary B lymphocytes, leads to a persistent nuclear accumulation of RelB
32. Regulation of major histocompatibility complex class I expression by NF-κB-related proteins in breast cancer cells
33. Could endogenous self-peptides presented by dendritic cells initiate rheumatoid arthritis?
34. Presentation of self peptides by dendritic cells: Possible implications for the pathogenesis of rheumatoid arthritis
35. Identification of immunostimulatory dendritic cells in the synovial effusions of patients with rheumatoid arthritis
36. The distinct surface of human blood dendritic cells, as observed after an improved isolation method
37. Immunohistological reassessment of accessory cell populations in normal and diseased human synovium
38. Dendritic cells and the pathogenesis of rheumatoid arthritis
39. Proliferation in monocyte-derived dendritic cell cultures is caused by progenitor cells capable of myeloid differentiation
40. Synovial fluid transforming growth factor β inhibits dendritic cell-T lymphocyte interactions in patients with chronic arthritis
41. The presence of interleukin-13 in rheumatoid synovium and its antiinflammatory effects on synovial fluid macrophages from patients with rheumatoid arthritis
42. Immature human monocyte-derived dendritic cells migrate rapidly to draining lymph nodes after intradermal injection for melanoma immunotherapy
43. Tumor metastasis biopsy as a surrogate marker of response to melanoma immunotherapy
44. Decrease in cellularity and expression of adhesion molecules by anti-tumor necrosis factor α monoclonal antibody treatment in patients with rheumatoid arthritis
45. Tumor necrosis factor blockade in actively induced experimental autoimmune encephalomyelitis prevents clinical disease despite activated T cell infiltration to the central nervous system
46. Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor α
47. Expression of CD28, CTLA4, CD80, and CD86 molecules in patients with autoimmune rheumatic diseases: Implications for immunotherapy
48. Dendritic cells use macropinocytosis and the mannose receptor to concentrate macro-molecules in the major histocompatibility complex class II compartment: Downregulation by cytokines and bacterial products